Back
Janux Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
JANX
Janux Therapeutics
Last Price:
$32.27
Seasonality Move:
-2.6%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight selling pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.19 | Buy |
20-day SMA: | 28.25 | Buy |
50-day SMA: | 30.87 | Buy |
200-day SMA: | 43.53 | Sell |
8-day EMA: | 30.29 | Buy |
20-day EMA: | 29.53 | Buy |
50-day EMA: | 32.19 | Sell |
200-day EMA: | 39.12 | Sell |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 55.36 | Buy |
Chaikin Money Flow: | -4874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.55 - 30.85) | Buy |
Bollinger Bands (100): | (28.98 - 52.48) | Sell |
Janux Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 31.05 while JANX 8-day simple moving average is 30.19, which is a Buy signal.
-
The stock price of JANX is 31.05 while Janux Therapeutics 20-day SMA is 28.25, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 30.87 while JANX share price is 31.05, making it a Buy technically.
-
JANX stock price is 31.05 and Janux Therapeutics 200-day simple moving average is 43.53, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
50
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $31.05. The Score for JANX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.8B
Price in USD:
31.05
Share Volume:
419.1K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.52
Sell
50
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 31.05 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 31.05 while JANX 8-day exponential moving average is 30.29, which is a Buy signal.
-
The stock price of JANX is 31.05 while Janux Therapeutics 20-day EMA is 29.53, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 32.19 while JANX share price is 31.05, making it a Sell technically.
-
JANX stock price is 31.05 and Janux Therapeutics 200-day simple moving average is 39.12, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.34 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 55.36, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is (26.55 - 30.85), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (28.98 - 52.48), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.